13F-HR filed by Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB filed this 13F-HR for the quarter ended 2016-06-30, filed 2016-08-01, with 97 holding rows worth $563,148,000.
- Accession
- 0001415889-16-006640
- Filer
- CIK 1599882
- Filed
- 2016-08-01
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2016
A holdings report, 97 entries on the cover page, a total value of $563,148,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $563,148,000 with VALUE read as thousands by filing date, 13F file number 028-15944. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 223,082 | $26,047,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 240,000 | $20,021,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 199,000 | $19,627,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 80,000 | $19,346,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 235,000 | $18,506,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 49,500 | $17,287,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 170,000 | $13,597,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 375,000 | $13,204,000 | thousands by filing date | |
| CIGNA CORPORATION | 125509109 | COM | 99,000 | $12,671,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 52,000 | $12,017,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 85,000 | $12,002,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 150,000 | $11,670,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 120,000 | $11,489,000 | thousands by filing date | |
| ABIOMED INC | 003654100 | COM | 105,000 | $11,475,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 127,000 | $11,020,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 195,000 | $10,821,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 137,000 | $10,076,000 | thousands by filing date | |
| ENDO INTL PLC | G30401106 | SHS | 635,200 | $9,903,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 70,000 | $9,892,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 61,500 | $9,357,000 | thousands by filing date | |
| EXPRESS SCRIPTS HLDG CO | 30219G108 | COM | 116,000 | $8,793,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 71,000 | $8,547,000 | thousands by filing date | |
| AETNA INC NEW | 00817Y108 | COM | 67,000 | $8,183,000 | thousands by filing date | |
| CEPHEID | 15670R107 | COM | 260,000 | $7,995,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 111,712 | $7,973,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 100,000 | $7,701,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 70,000 | $6,981,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 470,000 | $6,688,000 | thousands by filing date | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 82,000 | $6,397,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 800,000 | $6,248,000 | thousands by filing date | |
| HOLOGIC INC | 436440101 | COM | 180,000 | $6,228,000 | thousands by filing date | |
| CENCORA INC COM | 03073E105 | Stock | 78,000 | $6,187,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 370,000 | $6,094,000 | thousands by filing date | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 45,000 | $5,862,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 135,599 | $5,861,000 | thousands by filing date | |
| PEDIATRIX MEDICAL GROUP INC | 58502B106 | COM | 80,000 | $5,794,000 | thousands by filing date | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 280,000 | $5,704,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 30,000 | $5,600,000 | thousands by filing date | |
| WALGREENS BOOTS ALLIANCE INC | 931427108 | COM | 65,300 | $5,438,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 435,000 | $5,420,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 30,000 | $5,396,000 | thousands by filing date | |
| Lion Biotechnologies | 53619R102 | COM | 650,000 | $5,265,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 40,000 | $5,254,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 60,000 | $5,161,000 | thousands by filing date | |
| MEDIVATION INC | 58501N101 | COM | 80,000 | $4,824,000 | thousands by filing date | |
| CERNER CORP | 156782104 | COM | 81,000 | $4,747,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 625,000 | $4,619,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 115,000 | $4,464,000 | thousands by filing date | |
| OMNICELL COM COM | 68213N109 | Stock | 128,537 | $4,400,000 | thousands by filing date | |
| ZELTIQ AESTHETICS INC | 98933Q108 | COM | 160,000 | $4,373,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 55,000 | $4,363,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 70,000 | $4,334,000 | thousands by filing date | |
| THE COOPER COMPANIES | 216648402 | COM NEW | 25,000 | $4,289,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 225,000 | $4,273,000 | thousands by filing date | |
| VALEANT PHARMACEUTICALS INTL | 91911K102 | COM | 210,000 | $4,229,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 54,300 | $4,005,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 140,000 | $3,779,000 | thousands by filing date | |
| RADIUS HEALTH INC | 750469207 | COM NEW | 100,000 | $3,675,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 70,000 | $3,516,000 | thousands by filing date | |
| KITE PHARMA INC | 49803L109 | COM | 70,000 | $3,500,000 | thousands by filing date | |
| Abbott Laboratories | 002824100 | COM | 84,100 | $3,306,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 145,300 | $3,150,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 220,000 | $2,992,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 450,111 | $2,980,000 | thousands by filing date | |
| CEMPRA INC | 15130J109 | COM | 171,000 | $2,820,000 | thousands by filing date | |
| BECTON DICKINSON & CO | 075887109 | COM | 15,000 | $2,544,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 82,000 | $2,480,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 105,000 | $2,478,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 144,546 | $2,349,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 131,357 | $2,219,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 150,000 | $2,187,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 550,000 | $2,162,000 | thousands by filing date | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 250,000 | $2,158,000 | thousands by filing date | |
| COMMUNITY HEALTH SYSTEMS INC | 203668108 | COMMON STOCK | 175,000 | $2,109,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 266,000 | $2,075,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 130,000 | $1,968,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 850,000 | $1,896,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 114,000 | $1,871,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 40,000 | $1,818,000 | thousands by filing date | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 20,000 | $1,813,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 50,000 | $1,623,000 | thousands by filing date | |
| Tandem Diabetes Care, Inc. | 875372104 | COM | 209,000 | $1,576,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 140,000 | $1,383,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 370,000 | $1,317,000 | thousands by filing date | |
| TETRAPHASE PHARMACEUTICALS INC | 88165N105 | COMMON STOCK | 300,000 | $1,290,000 | thousands by filing date | |
| CATABASIS PHARMACEUTICALS IN | 14875P107 | COM | 345,100 | $1,277,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K101 | COM | 350,000 | $1,012,000 | thousands by filing date | |
| ANTHERA PHARMACEUTCLS INC | 03674U201 | Common equity shares | 300,000 | $927,000 | thousands by filing date | |
| QUORUM HEALTH CORP | 74909E106 | COM | 56,250 | $602,000 | thousands by filing date | |
| OREXIGEN THERAPEUTICS INC | 686164104 | COMMON STOCK | 1,200,000 | $516,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 10,000 | $489,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 154,006 | $487,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 30,099 | $338,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 50,000 | $273,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 40,000 | $198,000 | thousands by filing date | |
| GLAUKOS CORP COM | 377322102 | Stock | 5,100 | $149,000 | thousands by filing date | |
| THRESHOLD PHARMACEUTICAL INC | 885807206 | COM NEW | 201,537 | $128,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001415889-16-006640 | this filing | 2016-08-01 | acceptance time not in the bulk data set |